Cargando…

Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198

Vitetta and colleagues identified and characterized a putative vascular leak peptide (VLP) consensus sequence in recombinant ricin toxin A-chain (RTA) that contributed to dose-limiting human toxicity when RTA was administered intravenously in large quantities during chemotherapy. We disrupted this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Janosi, Laszlo, Compton, Jaimee R., Legler, Patricia M., Steele, Keith E., Davis, Jon M., Matyas, Gary R., Millard, Charles B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640533/
https://www.ncbi.nlm.nih.gov/pubmed/23364220
http://dx.doi.org/10.3390/toxins5020224
_version_ 1782267926090350592
author Janosi, Laszlo
Compton, Jaimee R.
Legler, Patricia M.
Steele, Keith E.
Davis, Jon M.
Matyas, Gary R.
Millard, Charles B.
author_facet Janosi, Laszlo
Compton, Jaimee R.
Legler, Patricia M.
Steele, Keith E.
Davis, Jon M.
Matyas, Gary R.
Millard, Charles B.
author_sort Janosi, Laszlo
collection PubMed
description Vitetta and colleagues identified and characterized a putative vascular leak peptide (VLP) consensus sequence in recombinant ricin toxin A-chain (RTA) that contributed to dose-limiting human toxicity when RTA was administered intravenously in large quantities during chemotherapy. We disrupted this potentially toxic site within the more stable RTA1-33/44-198 vaccine immunogen and determined the impact of these mutations on protein stability, structure and protective immunogenicity using an experimental intranasal ricin challenge model in BALB/c mice to determine if the mutations were compatible. Single amino acid substitutions at the positions corresponding with RTA D75 (to A, or N) and V76 (to I, or M) had minor effects on the apparent protein melting temperature of RTA1-33/44-198 but all four variants retained greater apparent stability than the parent RTA. Moreover, each VLP(−) variant tested provided protection comparable with that of RTA1-33/44-198 against supralethal intranasal ricin challenge as judged by animal survival and several biomarkers. To understand better how VLP substitutions and mutations near the VLP site impact epitope structure, we introduced a previously described thermal stabilizing disulfide bond (R48C/T77C) along with the D75N or V76I substitutions in RTA1-33/44-198. The D75N mutation was compatible with the adjacent stabilizing R48C/T77C disulfide bond and the T(m) was unaffected, whereas the V76I mutation was less compatible with the adjacent disulfide bond involving C77. A crystal structure of the RTA1-33/44-198 R48C/T77C/D75N variant showed that the structural integrity of the immunogen was largely conserved and that a stable immunogen could be produced from E. coli. We conclude that it is feasible to disrupt the VLP site in RTA1-33/44-198 with little or no impact on apparent protein stability or protective efficacy in mice and such variants can be stabilized further by introduction of a disulfide bond.
format Online
Article
Text
id pubmed-3640533
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-36405332013-05-03 Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198 Janosi, Laszlo Compton, Jaimee R. Legler, Patricia M. Steele, Keith E. Davis, Jon M. Matyas, Gary R. Millard, Charles B. Toxins (Basel) Article Vitetta and colleagues identified and characterized a putative vascular leak peptide (VLP) consensus sequence in recombinant ricin toxin A-chain (RTA) that contributed to dose-limiting human toxicity when RTA was administered intravenously in large quantities during chemotherapy. We disrupted this potentially toxic site within the more stable RTA1-33/44-198 vaccine immunogen and determined the impact of these mutations on protein stability, structure and protective immunogenicity using an experimental intranasal ricin challenge model in BALB/c mice to determine if the mutations were compatible. Single amino acid substitutions at the positions corresponding with RTA D75 (to A, or N) and V76 (to I, or M) had minor effects on the apparent protein melting temperature of RTA1-33/44-198 but all four variants retained greater apparent stability than the parent RTA. Moreover, each VLP(−) variant tested provided protection comparable with that of RTA1-33/44-198 against supralethal intranasal ricin challenge as judged by animal survival and several biomarkers. To understand better how VLP substitutions and mutations near the VLP site impact epitope structure, we introduced a previously described thermal stabilizing disulfide bond (R48C/T77C) along with the D75N or V76I substitutions in RTA1-33/44-198. The D75N mutation was compatible with the adjacent stabilizing R48C/T77C disulfide bond and the T(m) was unaffected, whereas the V76I mutation was less compatible with the adjacent disulfide bond involving C77. A crystal structure of the RTA1-33/44-198 R48C/T77C/D75N variant showed that the structural integrity of the immunogen was largely conserved and that a stable immunogen could be produced from E. coli. We conclude that it is feasible to disrupt the VLP site in RTA1-33/44-198 with little or no impact on apparent protein stability or protective efficacy in mice and such variants can be stabilized further by introduction of a disulfide bond. MDPI 2013-01-30 /pmc/articles/PMC3640533/ /pubmed/23364220 http://dx.doi.org/10.3390/toxins5020224 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Janosi, Laszlo
Compton, Jaimee R.
Legler, Patricia M.
Steele, Keith E.
Davis, Jon M.
Matyas, Gary R.
Millard, Charles B.
Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
title Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
title_full Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
title_fullStr Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
title_full_unstemmed Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
title_short Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
title_sort disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate rta1-33/44-198
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640533/
https://www.ncbi.nlm.nih.gov/pubmed/23364220
http://dx.doi.org/10.3390/toxins5020224
work_keys_str_mv AT janosilaszlo disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198
AT comptonjaimeer disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198
AT leglerpatriciam disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198
AT steelekeithe disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198
AT davisjonm disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198
AT matyasgaryr disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198
AT millardcharlesb disruptionoftheputativevascularleakpeptidesequenceinthestabilizedricinvaccinecandidaterta13344198